A Comparative Prospective Study of the Arthroscopic Meniscal Repair Methods
1 other identifier
interventional
100
1 country
2
Brief Summary
Performing arthroscopic meniscus repair following a traumatic meniscus tear as an alternative to a meniscectomy is now an acceptable choice. Preserving meniscus tissues is crucial due to the significant role they play as an essential part of the knee joint. It is essential to comprehend the additional tools that can impact the recovery of the meniscus after suturing. Patients have been randomly assigned into two groups using the computer "www.randomiser.org," and the treatment outcomes were compared after one year. One group of patients has received a standard meniscus suturing technique, whereas another group has experienced the meniscus suturing treatment with an additional fibrin clot approach. Data pertaining to demographics, clinical characteristics, radiological findings, and survey responses have been carefully collected prospectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 26, 2021
CompletedFirst Submitted
Initial submission to the registry
December 10, 2023
CompletedFirst Posted
Study publicly available on registry
December 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2026
ExpectedAugust 28, 2025
August 1, 2025
4.3 years
December 10, 2023
August 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pediatric International Documentation Committee Subjective (Pedi-IKDC) Knee Form.
Pedi-IKDC is used to measure knee-related symptoms, function, and sports activity among children. The questionnaire consists of 13 items, each of which is scored using one of three rating systems: a range of 0 to 10 for items 2, 3, 12, and 13, a range of 0 to 4 for items 1, 4, 5, 6, 9, and 10, and a range of 0 to 1 for items 7 and 8. The 11th item consists of nine subquestions, each of which can be scored from 0 to 4. The overall score value is calculated by adding only the responses to 12 items and dividing the total by 92 (the highest number of points attainable). The score runs from 0 (worst case scenario) to 100 (best case scenario). The Pedi-IKDC has been proven to be a valid, trustworthy, and responsive questionnaire in a paediatric population with varied knee disorders, especially ligament and meniscal injuries, joint instability, and other disorders
before treatment, after 12 months and 24 months following treatment
Lysholm knee scale
Lysholm knee scoring scale has been proven to be suitable for a variety of knee pathologies and also for the adolescent population. The scale comprises eight items. Higher values of the score indicate better functioning of the knee. (range from 0 to 100).
before treatment, after 12 months and 24 months following treatment
Health-related paediatric quality of life (PedsQL)
PedsQL is a generic score, which estimates the quality of life of paediatric patients. The questionnaire consists of four domains with 23 questions: the general physical functioning, emotional, social, and functioning at school domains
before treatment, after 12 months and 24 months following treatment
Secondary Outcomes (3)
Clinical evaluation at 12 and 24 months postoperatively. The clinical assessment involves evaluating of pain, swelling and estimating and comparing the range of motion of the knee with the contralateral side.
12 and 24 months postoperatively.
magnetic resonance imaging (MRI scan) of the knee
before treatment, after 12 months and 24 months following treatment
Revision rates (secondary arthroscopies)
12 and 24 month following primary surgery
Study Arms (2)
Cohort I of patients
OTHERIndividuals who undergo the conventional arthroscopic meniscus repair procedure
Cohort II of patients
OTHERPatients who receive the supplementary fibrin clot augmentation during the arthroscopic meniscus repair operation.
Interventions
A traditional two-portal arthroscopic approach is utilized. The meniscal edges are examined using a probe, and any meniscal tears that are not stable are evaluated for potential repair. For meniscus repair, sutures have been made using the "all-inside" or "outside-inside" and "inside-outside" techniques. If the procedure involving the addition of a fibrin clot is being carried out, a volume of approximately 60 milliliters of blood is taken and thereafter transferred into a basin. An assistant is able to stir the blood using a glass syringe for approximately fifteen minutes to ensure sufficient coagulation surrounding the syringe. After a sufficient clot has developed at the end of the syringe, a grasper is used to insert the clot through the anterolateral arthroscopy portal. The meniscal sutures are intentionally loosened to accommodate the clot in the meniscus, ensuring optimal contact with the lesion. Subsequently, the sutures are fastened and knotted.
Eligibility Criteria
You may not qualify if:
- This investigation excludes patients with developmental disabilities who are unable to read or interpret in their native language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vilnius Universitylead
- Vilnius University Hospital Santaros Klinikoscollaborator
Study Sites (2)
Vilnius University, Medical faculty
Vilnius, LT-03101, Lithuania
Vilnius University Hospital Santaros Klinikos
Vilnius, LT-08661, Lithuania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Viktorija Brogaite Martinkeniene MD
Study Record Dates
First Submitted
December 10, 2023
First Posted
December 19, 2023
Study Start
May 26, 2021
Primary Completion
September 26, 2025
Study Completion (Estimated)
December 26, 2026
Last Updated
August 28, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
As per the study protocol, the IPD has no intention of disclosing the information to third parties or other researchers. In accordance with the data analysis and verification process, the main author of the research could be requested for the provision of anonymized data.